Health and Healthcare
Pfizer (PFE) Does Some Good, Viagra Rocks On
Published:
Last Updated:
Once all of the one-time charges were washed out of the numbers, Pfizer recorded adjusted income of $4.2 billion, an increase of 5% compared with $4.0 billion in the year-ago quarter, and EPS of $.62, an increase of 7% compared with $.58 in the year-ago quarter. The firm hit these numbers despite a drop in sales of its Zyrtec and Camptosar products.
Viagra and Lipitor continued to do well, a bit of a commentary on life in the US in 2008.
Perhaps most important, Pfizer upped its forecasts. The pharma firm raised the lower end of its guidance range for full-year 2008 revenues to $48.0 to $49.0 billion from $47.0 to $49.0 billion.
All in all, a pretty outstanding set of numbers
Douglas A. McIntyre
Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)
Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.
Click here now to get started.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
